{"id":"W2139785591","doi":"10.1056/nejmoa1207541","title":"Apixaban for Extended Treatment of Venous Thromboembolism","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1341,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"Sanofi; Bayer HealthCare; GlaxoSmithKline; Pfizer; Daiichi Sankyo Europe; Bristol-Myers Squibb","keywords":"Apixaban; Venous thromboembolism; Medicine; Regimen; Intensive care medicine; Internal medicine; Atrial fibrillation; Rivaroxaban; Thrombosis; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001725784,0.0003999793,0.00149133,0.000246775,0.0001556096,0.0004096338,0.0004265942,0.0005443925,0.003699329],"category_scores_gemma":[0.001707184,0.0001274207,0.000676107,0.000242089,0.0003906668,0.0003171052,0.0002542005,0.00133402,0.0003800057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001931229,"about_ca_system_score_gemma":0.0003621411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009307153,"about_ca_topic_score_gemma":0.0001208458,"domain_scores_codex":[0.9991961,0.0004572138,0.0000930215,0.00007322442,0.0001379136,0.00004252041],"domain_scores_gemma":[0.9989997,0.0003530619,0.000372776,0.00005947325,0.00006394053,0.0001510872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.286258,0.004907145,0.01004948,0.008087961,0.003290543,0.001582904,0.0001819203,0.001433825,0.03847246,0.002901631,0.01096249,0.6318718],"study_design_scores_gemma":[0.5834777,0.2218609,0.07063583,0.001974569,0.002968096,0.01230131,0.00008858627,0.002812299,0.009989663,0.003310588,0.09049117,0.00008932866],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6212501,0.3585207,0.005262459,0.00461713,0.002492912,0.001149983,0.0005465259,0.000185993,0.005974253],"genre_scores_gemma":[0.9438049,0.04632958,0.003448811,0.001568447,0.002217809,0.0007396441,0.0004224882,0.00001455118,0.001453756],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003699329,"threshold_uncertainty_score":0.01237547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1024440574879457,"score_gpt":0.3778103075848138,"score_spread":0.2753662500968681,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}